Special Instructions 015 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002
Closed Special Notice Posted
Not the latest version. See the latest special notice from .
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Washington, District of Columbia 20201, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response published Special Instructions 015 updating its Easy Broad Agency Announcement BAA-20-100-SOL-0002. The Special Instructions add an area of interest on mitigating long-term effects of respiratory distress, remind respondents that areas of interest on topics including infection severity, host-targeted therapeutics, laboratory testing, digital health tools, and diagnostics remain open for abstract submissions through dates in 2022 and 2023.
The Special Notice informs contractors of changes to the agency's research priorities and requirements. It provides deadlines ranging from April 2022 to April 2023 for submitting abstracts to multiple open areas of interest focused on respiratory distress, diagnostics, and digital health solutions. Contractors must request a market research call to receive business terms and are notified that contracts awarded after November 14, 2021 will be subject to COVID safety protocols for federal contractors. The agency seeks to advance candidate products that can accelerate pandemic response and will make multiple awards for proposals submitted under the research areas of interest, with priority given to non-traditional government contractors. Eligibility is not restricted under the announcement.
Notice text
Under these Special Instructions 015, BARDA is announcing the following as part of its EZ-BAA (BAA-20-100-SOL-0002):
1. Add Area of Interest (AOI) #12 Mitigating Long-term Effects (MILE) of Respiratory Distress to the EZ-BAA.
2. Remind potential Respondents that the following AOIs under the EZ-BAA are currently open and accepting abstract submissions:
AOI #2: Infection Severity and Solving Sepsis
AOI #6: Beyond the Needle
AOI #8: Bringing Laboratory Testing to the Home
AOI #9: Digital Health Tools for Pandemic Preparedness
AOI #10: Next Generation Sequencing (NGS)-based Agnostic Diagnostic for Respiratory RNA Virus Pathogens
AOI #11a: Home-based, Over-the-Counter Diagnostics for the Detection of SARS-CoV-2
AOI #11b: Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection
AOI #12: Mitigating Long-term Effects (MILE) of Respiratory Distress
3. Notify potential Respondents that any EZ-BAA contracts (above the micro-purchase threshold) awarded on or after November 14, 2021 will be subject to Class Deviation (2021-03) from the Federal Acquisition Regulation (FAR) Regarding Implementation of Executive Order 14042, Ensuring Adequate COVID Safety Protocols for Federal Contractors.
Files
| File | Type | Posted |
|---|---|---|
| DRIVe EZ-BAA - Special Instructions 015.pdf |
Notice history
Show 5 more
15 notices listed here. See the rest on GovTribe.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity